Zacks Investment Research
Constellium Shares Up 36% YTD: Is It the Right Time to Buy the Stock?
Constellium SE (CSTM) has gained 35.8% year-to-date, outperforming its industry despite recent technical weakness. The company benefits from strong aerospace, packaging, and defense demand, delivering record segment EBITDA in key divisions. With expected 2026 free cash flow exceeding $300 million and a reasonable valuation, analysts maintain a Buy rating despite bearish technical indicators showing a death crossover.
